Hepatic hemangioma is a surgical disease, traditionally classified under general surgery or hepatobiliary surgery, and mainly treated by surgery, which is more cautious for both doctors and patients due to the high risk of trauma. The mainstream view of surgeons is that patients larger than 4 cm, symptomatic and requiring treatment can be treated with surgery; for asymptomatic hemangiomas smaller than 4 cm, treatment is not advocated and observation is favored. However, the smaller the tumor is, the more difficult the imaging diagnosis is and the higher the misdiagnosis rate is. Some literature statistics show that for every 100 cases of hepatic hemangioma diagnosed by CT, MRI and ultrasound, 5 cases are finally diagnosed as liver cancer, therefore, whether to operate or not to operate sometimes becomes a very tangled issue for both doctors and patients. Nowadays, ultrasound-guided, percutaneous liver tissue intervention is a good solution to this problem. The method is safe, effective and simple, effective for large tumors and even more effective for small ones, which can well relieve patients’ physical and psychological burdens.